Publication | Closed Access

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

Novel Catechol-o-methyltransferase InhibitorMitochondrial FunctionBiochemistryMedicineNeuropharmacologyNeuroprotectionMitochondrial Energy ProductionPharmacologyOxidative Stress